Jul 13, 2026 • 8:00 AM EDT Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
Jun 26, 2026 • 5:15 PM EDT Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
Apr 3, 2026 • 5:00 PM EDT Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
